TLR2 and B-cell chronic lymphocytic leukemia: Further in vitro studies demonstrated that the TLR2/1 and TLR2/6 ligands, PAM3CSK4 and MALP-2 (mycoplasmal macrophage-activating lipopeptide-2), protected CLL cells from spontaneous apoptosis.